Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2

Molecular Carcinogenesis

Volumn 15, Issue 3, 1996, Pages 227-238

  Ram, Tracy G ^a   Dilts, Cheryl A ^a   Dziubinski, Michele L ^a   Pierce, Lori J ^a   Ethier, Stephen P ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Gene amplification; Mammary epithelium; Transformation; Tumor progression; Tyrosine kinase receptors

Indexed keywords

EPIDERMAL GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; SOMATOMEDIN; TYROSINE KINASE RECEPTOR;

ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; ONCOGENE C ERB; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR GROWTH;

BASE SEQUENCE; BREAST; BREAST NEOPLASMS; CELL DIVISION; EPIDERMAL GROWTH FACTOR; FEMALE; GENE AMPLIFICATION; GENES, ERBB-2; GLYCOPROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MOLECULAR SEQUENCE DATA; NEUREGULINS; PHOSPHORYLATION; RECEPTOR, ERBB-2; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0029929513     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199603)15:3<227::AID-MC8>3.0.CO;2-E     Document Type: Article

References (71)

1. Coussens L, Yang-Feng TL, Liao Y-C, et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene Science 230 1132-1139, 1985
2. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family. Evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86:9193-9197, 1989.
3. erbB4, a fourth member of the epidermal growth factor receptor family Proc Natl Acad Sci USA 90:1746-1750, 1993.
4. Ullrich A, Schlessinger J Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212, 1990
5. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL Human breast cancer Correlation of relapse survival with amplification of the HER-2/neu oncogene Science 235.177-182, 1987.
6. Zhou D, Battifora H, Yokota J, Yamamoto T, Cline MJ. Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer Cancer Res 47.6123-6125, 1987
7. Varley JM, Swallow JE, Brammar WJ, Whittaker JL, Walker RA Alterations to either c-erbB-2 (neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis Oncogene 1 423-430, 1987
8. Van de Vijver MJ, Peterse JL, Mooi WJ, et al neu-protein overexpression in breast cancer. N Engl J Med 319 1239-1245, 1988
9. Berger MS, Locher GW, Saurer S, et al. Correlation of c-erbB-2 gene amplification and protein expression in human breast car-cinoma with nodal status and nuclear grading Cancer Res 48.1238-1243, 1988.
10. Ro J, El-Naggar A, Ro JY, et al. c-erbB-2 amplification in nodenegative human breast cancer. Cancer Res 49:6941-6944, 1989.
11. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712, 1989.
12. Kraus MH, Popescu NC, Amsbaugh SC, King CR Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6:605-610, 1987.
13. Hollywood DP, Hurst HC. A novel transcription factor, OB2-1, is required for overexpression of proto-oncogene c-erbB-2 in mammary tumour lines EMBO J 12:2369-2375, 1993.
14. FRBB2 expression and the gene amplification Cancer Res 50 8002-8009, 1990
15. neu) in normal and transformed epithelial tissues of the digestive tract. Oncogene 4.81-88, 1989.
16. neu expression in human lung adenocarcinomas predicts shortened survival Cancer Res 50:5184-5191, 1990.
17. Williams TM, Weiner DB, Greene MI, Maguire HC. Expression of c-erbB-2 in human pancreatic adenocarcinomas. Pathobiology 59:46-52, 1991.
18. Al-Kasspooles M, Moore JH, Orringer MB, Beer DG Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int J Cancer 54:213-219, 1993.
19. neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2 Oncogene 5.879-883, 1990
20. Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, Aaronson SA erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237 178-182, 1987.
21. HER2 causes transformation and tumorigenesis of NIH 3T3 cells Proc Natl Acad Sci USA 84:7159-7163, 1987
22. Di Marco E, Pierce JH, Knicley CL, Di Fiore PP. Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of rat neu gene Mol Cell Biol 10 3247-3252, 1990.
23. Di Fiore PP, Segatto O, Lonardo F, Fazioli F, Pierce JH, Aaronson SA The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. Mol Cell Biol 10:2749-2756, 1990.
24. Lonardo F, Di Marco E, King CR, et al The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand New Biologist 2:992-1003, 1990.
25. Lemoine NR, Staddon S, Dickson C, Barnes DM, Gullick WJ Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene 5:237-239, 1990.
26. Ethier SP, Cundiff KC. Importance of extended growth potential and growth factor independence on in vivo neoplastic potential of primary rat carcinoma cells. Cancer Res 47 5316-5322, 1987.
27. Ethier SP, Chiodino C, Jones RF. Role of growth factor synthesis in the acquisition of insulin/insulin-like growth factor I independence in rat mammary carcinoma cells Cancer Res 50:5351-5357, 1990.
28. Ethier SP, Moorthy R, Dilts C. Secretion of an epidermal growth factor-like growth factor by epidermal growth factor-independent rat mammary carcinoma cells. Cell Growth Diff 2:593-602, 1991.
29. Stampfer MR, Hallowes RC, Hackett AJ. Growth of normal human mammary epithelial cells in culture. In Vitro 16:415-425, 1980.
30. Hammond SL, Ham RG, Stampfer MR. Serum-free growth of human mammary epithelial cells: Rapid clonal growth in defined medium and extended serial passage with pituitary extract Proc Natl Acad Sci USA 81:5435-5439, 1984
31. Ethier SP, Summerfelt RM, Cundiff KC, Asch SB The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells Breast Cancer Res Treat 17 221-230, 1990.
32. Band V, Sager R Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci USA 86:1249-1253, 1989.
33. Band V, Zajchowski D, Stenman G, et al. A newly established metastatic breast tumor cell line with integrated amplified copies of erbB2 and double minute chromosomes. Genes Chromosom Cancer 1.48-58, 1989.
34. Band V, Zajchowski D, Swisshelm K, et al Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res 50:7351-7357, 1990
35. Band V, Sager R. Tumor progression in breast cancer In Rhirn JS, Dritschilo A (eds), Neoplastic Transformation in Human Cell Culture Humana Press Inc., Totowa, NJ, 1991, pp. 169-178.
36. Carraway KL, Sliwkowski MX, Akita R, et al The erbB3 gene product is a receptor for heregulin J Biol Chem 269:14303-14306, 1994.
37. Sliwkowski MX, Schaefer G, Akita RW, et al. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin J Biol Chem 269.14661-14665, 1994
38. Kita YA, Barff J, Duanzhi W, et al. NDF/heregulin stimulates the phosphorylation of Her3/erbB3 FEBS 349:139-143, 1994.
39. erbB4. Nature 366:473-475, 1993.
40. Ausubel FM, Brent R, Kingston RE, et al Current Protocols in Molecular Biology Greene Publishing and John Wiley & Sons, New York, 1989.
41. Laborda J. 3684 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19:3998, 1991.
42. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162.156-159, 1987.
43. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989
44. Ethier SP Primary culture and serial passage of normal and carcinogen-treated rat mammary epithelial cells in vitro. J Natl Cancer Inst 74: 1307-1318, 1985
45. Soule HD, Maloney TM, Wolman SR, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086, 1990
46. Ciardiello F, Gottardis M, Basolo F, et al Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-α genes on in vitro transformation of human mammary epithelial cells Mol Carcinog 6:43-52, 1992.
47. Rohlik QT, Adams D, Kull Jr FC, Jacobs S An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture Biochem Biophys Res Commun 149:275-281, 1987.
48. Sato JD, Kawamoto T, Le AD, Mendelsohn J, Polikoff J, Sato GH. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med 1:511-529, 1983
49. Wen D, Peles E, Cupples R, et al. Neu differentiation factor. A transmembrane glycoprotein containing an EGF domain and an immunoglobin homology unit. Cell 69 559-572, 1992.
50. erbB-2 Science 256:1205-1210, 1992.
51. Ram TG, Kokeny KE, Dilts CA, Ethier SP. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells. J Cell Physiol 163:589-596, 1995
52. Pierce JH, Arnstein P, DiMarco E, et al Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 6:1189-1194, 1991
53. Peles E, Ben-Levy R, Or E, Ullrich A, Yarden Y. Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C γ. EMBO J 10 2077-2087, 1991.
54. Fazioli F, Kim U-H, Rhee SG, Molloy CJ, Segatto O, Di Fiore PP. The erbB-2 mitogenic signaling pathway: Tyrosme phosphorylation of phospholipase C-γ and GTPase-activating protein does not correlate with erbB-2 mitogenic potency Mol Cell Biol 11:2040-2048, 1991.
55. Peles E, Lamprecht R, Ben-Levy R, Tzahar E, Yarden Y. Regulated coupling of the neu receptor to phosphatidylinositol 3′-kinase and its release by oncogenic activation J Biol Chem 267:12266-12274, 1992.
56. Kraus MH, Fedi P, Starks V, Muraro R, Aaronson SA. Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells. Proc Natl Acad Sci USA 90.2900-2904, 1993.
57. Fedi P, Pierce JH, Di Fiore PP, Kraus MH. Efficient coupling with phosphatidylmositol 3-kinase, but not phospholipase Cγ or GTPase-activating protein, distinguishes erbB-3 signaling from that of other erbB/EGFR family members Mol Cell Biol 14.492-500, 1994.
58. Carraway KL, Cantley LC. A neu acquaintance of erbB3 and erbB4: A role for receptor heterodimerization in growth signaling Cell 78:5-8, 1994.
59. Backer JM, Myers MG, Shoelson SE, et al. Phosphatidylmositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11:3469-3479, 1992.
60. Backer JM, Myers MG, Sun X-J, et al. Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3′-kinase. J Biol Chem 268 8204-8212, 1993.
61. Cheatham B, Vlahos CJ, Cheatham L, et al Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DMA synthesis, and glucose transporter translocation Mol Cell Biol 14:4902-4911, 1994
62. Soltoff SP, Carraway III KL, Prigent SA, Gullick WG, Cantley LC. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol Cell Biol 14 3550-3558, 1994.
63. Kim H-H, Sierke SL, Koland JG Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product J Biol Chem 269:24747-24755, 1994.
64. Janes PW, Daly RJ, deFazio A, Sutherland RL Activation of the ras signalling pathway in human breast cancer cells overexpressing erbB-2 Oncogene 9:3601-3608, 1994.
65. Soler C, Alvarez CV, Beguinot L, Carpenter G Potent SHC Tyrosine phosphorylation by epidermal growth factor at low density or in the absence of receptor autophosphorylation sites. Oncogene 9:2207-2215, 1994.
66. Marte BM, Graus-Porta D, Jeschke M, et al NDF/heregulin activates MAP kinase and p70/p85 56 kinase during proliferation or differentiation of mammary epithelial cells Oncogene 10:167-175, 1995.
67. King CR, Borrellol, Bellot F, Comoglio P, Schlessinger J. EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J 7.1647-1651, 1988
68. Goldman R, Ben Levy R, Peles E, Yarden Y. Heterodimenzation of the erbB-1 and erbB-2 receptors in human breast carcinoma cells. A mechanism for receptor transregulation Biochemistry 29:11024-11028, 1990
69. neu protein and EGF receptor modulates EGF receptor function. Cell 61:1339-1347, 1990.
70. Aaronson SA. Growth factors and cancer. Science 254: 1146-1153, 1991.
71. Falco JP, Taylor WG, DiFiore PP, Weissman BE, Aaronson SA. Interactions of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes. Oncogene 2 573-578, 1988.